Rifamycins can sharply reduce voriconazole exposure, review finds
A structured review found strong clinical evidence that rifamycins can markedly reduce voriconazole exposure, while evidence for most other antituberculosis ...
A structured review found strong clinical evidence that rifamycins can markedly reduce voriconazole exposure, while evidence for most other antituberculosis ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.